Just a month after taking up the CEO role at Legend Biotech, Frank Zhang has been forced to step aside by the board following an investigation into suspected illegal activity by Chinese customs.
As you can see from the chart above the percentage of shares that are sold short for Legend Biotech has declined since its last report. This does not mean that the stock is going to rise in the ...
In a report released on April 3, Leonid Timashev from RBC Capital maintained a Buy rating on Legend Biotech (LEGN – Research Report), with a price target of $84.00. The company’s shares closed ...
AstraZeneca has vowed to spend over $10 billion on R&D deals in Asia, focusing on China, amid ongoing fraud scandal ...
During the webcast and conference call, senior leaders will provide an overview of Legend Biotech’s quarter and fiscal year performance. Investors and other interested parties may join the live ...
“NOT GOOD” FOR BIOTECH SECTOR: RBC Capit Legend Biotech Corp (LEGN) reports a 110% increase in CARVYKTI sales, outlines expansion strategies, and anticipates profitability by 2026. Although ...
Coventry City will evoke the spirit of 1987 as Frank Lampard faces former Chelsea ... Dave Bennett and Trevor Peake will be part of a Legends Day parade at the Ricoh Arena as Lampard's play ...
This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox. A warm welcome to all my new ...
I also love the local legend that, after a disastrous concert at the Caird Hall, Frank Sinatra went there to drown his sorrows. I love that idea – I so hope it is true – and imagine that Ol ...
Shortly before he died, Frank posted a video on social media telling fans about a movie he had been working on that he was very proud of, titled Legend of the White Dragon. “He’s my best ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...